IOWA ONCOLOGY RESEARCH ASSOCIATION
[ Home ] [ Treatment ] [ Control & Prevention ] [ Physicians ] [ Contact Us ] [ Helpful Links ] [ Financial Conflict of Interest Policy ] [ Members ]

Lung Cancer Research Studies

NON-SMALL CELL
C30607    Randomized, Phase III, Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced Stage IIIB / IV Non-Small Cell Lung Cancer 

C30801    A Randomized Phase III Double-Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer

E1505    Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> 4cm)- IIIA Non-Small Cell Lung Cancer

E3508    A Phase II Randomized Trial of Paclitaxel, Carboplatin, Bevacizumab with or without IMC-A12 in Patients with Advanced Non-Squamous, Non-Small Cell Lung Cancer

E5508    Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

E6508    A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non-Squamous Non-Small Cell Lung Cancer After Definitive Chemoradiation

S0819    A Randomized Phase III Study Comparing Carboplatin / Paclitaxel or Carboplatin / Paclitaxel / Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

CANCER CONTROL
WFU-99311   Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation Among Cancer Survivors